Hepatocellular Carcinoma: understanding the genotoxic risks of liver-targeted gene therapy using recombinant AAV vectors
Hepatocellular Carcinoma: understanding the genotoxic risks of liver-targeted gene therapy using recombinant AAV vectors
批准号:
nhmrc : GNT1145116
负责人:
Prof Geoffrey McCaughan
金额:
$89.16万
依托单位国家:
澳大利亚
项目类别:
Project Grants
财政年份:
2018
资助国家:
澳大利亚
项目状态:
已结题
起止时间:
2018-01-01 至 --
中文摘要
点击翻译按钮获取中文摘要
英文摘要
Advances in gene transfer technology using an engineered virus known as AAV underpin success in the treatment of haemophila B, and offer the exciting prospect of treating many other liver diseases. While continued improvement of gene transfer efficiency is essential there is an equal need to focus on safety. We have discovered a genetic element in AAV that we believe is a key to unlocking accurate analysis of the safety of AAV-based gene transfer technology. Here we propose to turn the key.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
A novel liver cancer therapy targeting tumour stroma
-
批准号:nhmrc : GNT1113842
-
项目类别:Development Grants
-
资助金额:$38.79万
-
财政年份:2016
-
负责人:Prof Geoffrey McCaughan
-
依托单位:
DPP4 family proteases as drivers of chronic liver injury
-
批准号:nhmrc : GNT1105238
-
项目类别:Project Grants
-
资助金额:$73.0万
-
财政年份:2016
-
负责人:Prof Geoffrey McCaughan
-
依托单位:
海外基金